Detecting Alzheimer’s at an early stage gives patients the best chance to adjust, prepare, and plan for the future. The only problem is that diagnosing the disease can be very difficult. In search of a more effective method of detecting the disease, researchers from Germany created a virtual Read More...
The problem with treating Alzheimer’s is that once the symptoms start showing up, it’s already too late—meaning that early detection is absolutely vital in coming up with working solutions. Using the power of machine learning, IBM researchers have figured out a way to detect a biological Read More...
Scientists have reportedly discovered that the main pathogen behind gum disease is also found in the brains of deceased Alzheimer’s patients. This means that Alzheimer’s isn’t just a disease, but also an infection. Why is this important? Because it brings us one step closer to developing a Read More...
The inability to detect Alzheimer’s early is one main reason pharmaceutical companies have not been able to develop a drug to combat the disease, which is the most common form of dementia. That’s why it’s great news that researchers have just developed a simple blood test that shows evidence Read More...
Scientists tested the effects of tetrahydrocannabinol (THC), one of the active compounds in marijuana, and discovered that it can promote the removal of a protein responsible for the progression of Alzheimer’s. The finding supports the results of previous studies that found evidence of the Read More...
Researchers uncovered a remarkable treatment technique to reverse dementia with the help of ultrasound. By using high-frequency sound waves, scientists managed to clear toxic protein clumps from the brain without any additional therapeutic drugs. This is a major breakthrough that could make way for Read More...
Researchers say THC can impair or improve memory depending on age and disease. Findings suggest, in Alzheimer’s disease, the cannabis compound can help improve memory and mitigate some of the symptoms of the Read More...
While it is widely shown that possessing the ApoE4 gene is the major genetic risk factor of Alzheimer’s disease (AD), not all ApoE4 carriers develop AD. For the first time, researchers at Boston University School of Medicine (BUSM) have shown that ApoE4 linked with chronic inflammation Read More...
Despite predictions that up to 100 million people worldwide will be diagnosed with Alzheimer’s disease by 2050, pharmaceutical giants announced earlier this year that new research on therapeutics will be brought to a halt. Fortunately, the pursuit of a therapeutic treatment for Alzheimer’s has Read More...
Trials focused on preventing and treating Alzheimer’s have been largely unsuccessful in the past, and researchers believe this is because the treatments start too late. New research from King’s College London has identified ten proteins that could serve as indicators of the onset of Read More...